The Role of Digital Media in Reaching Rare Disease Patients
7,000 known rare diseases
30 million live with a rare disease
600 medications in development
Marketing to rare disease patients requires elements of traditional funnel-based marketing and partnership with a nexus of patients....
Colorado Requires Disclosure of Drug Prices – Will it survive where HHS’s regulation did...
What Will Happen when Drug Prices are Forced to be Disclosed in Colorado?
A new Colorado law recently came into effect on August 2nd 2019 and requires the disclosure of the wholesale...
“Cannons to the left of us, cannons to the right of us”— Charge of...
Uneasy lie the heads that wear the crowns of pharma companies – the game of thrones that is the US Presidential election season, employs them as pawns in their epic struggle...
The Lack of Price Transparency in the Pharma Industry
Pharmaceutical price transparency falls into the same oxymoronic category as the long-vaunted “paperless society” and the oldie but goodie, “airline food” (which used to be an oxymoron but now...
Cross-Functional Collaboration Drives Launch Success
The launch of a new therapeutic product is as exciting as it is challenging. The need to navigate the ever-growing complexity of the health care landscape, the evolution of...
The Top 3 Reasons Brands Are Turning to Regional Marketing in 2019
"In 2001, Pfizer started doing Regional Marketing to squeeze extra share/volume out of the Lipitor Brand (and a few other $1B blockbusters). I remember, when I was on...
What’s New at EHS?
Tap Native Selects
eHealthcare Solutions to Deliver its Unique In-Content Native Advertising
Opportunities to Pharma Brands
eHealthcare Solutions (EHS) recently announced an exclusive partnership with Tap Native....
Learnings from ExL Events and Paul Ivan’s Inaugural Digital Health for Pharma (DH4P) Conference
Digital health is growing exponentially. Its potential for positively impacting health outcomes is mind boggling. Yet, multiple obstacles continue to stand in the way of its success – from...
In PBMs’ Search for Survival, Transparency is the Answer
Within the last couple months, President Trump reiterated his intention to end the opioid crisis, notably adding, “we are holding big Pharma accountable.”
Drug manufacturers and...
An Update on Digital Health – Compliance Considerations
Artificial Intelligence (AI) holds the potential to change the health care experience for patients by providing new tools that modify the way patient engagement occurs and creating platforms that...
